Skip to main content
Episurf logo

Episurf — Investor Relations & Filings

Ticker · EPIS ISIN · SE0003491562 LEI · 549300GORBCSMHZB2J75 ST Manufacturing
Open in API
Filings indexed 872 across all filing types
Latest filing 2025-03-18 Board/Management Inform…
Country SE Sweden
Listing ST EPIS

About Episurf

https://episurf.com/

Episurf is a medical device company that develops and commercializes patient-specific solutions for treating painful joint injuries. The company's core technology utilizes 3D imaging to create personalized orthopedic implants and surgical instruments tailored to each patient's unique anatomy and cartilage defect. Its primary product line, the Episealer® system, provides minimally invasive implants for treating cartilage and underlying bone lesions in the knee and ankle joints. The objective of this individualized approach is to repair the joint, alleviate pain, and restore function, offering a treatment option for patients, often middle-aged, who are not yet candidates for total joint replacement surgery.

Recent filings

Filing Released Lang Actions
CFO Veronica Wallin lämnar Episurf Medical för ett nytt uppdrag
Board/Management Information Classification · 1% confidence The document is a short announcement detailing the departure of the Chief Financial Officer (CFO), Veronica Wallin, and the initiation of a recruitment process for her replacement. This type of announcement, concerning changes in senior management or the board of directors, directly corresponds to the definition for Board/Management Information (MANG). The document is short (2182 characters) and contains specific personnel change information, not a full financial report or a general regulatory filing.
2025-03-18 Swedish
CFO Veronica Wallin leaves Episurf Medical for a new position
Board/Management Information Classification · 1% confidence The document explicitly announces the resignation of the Chief Financial Officer (CFO), Veronica Wallin, and states when she will leave (Q2 2025). It includes quotes from the outgoing CFO and the CEO regarding the departure and mentions that a recruitment process for a new CFO has started. This content directly relates to changes in senior management personnel. Therefore, the appropriate classification is Board/Management Information (MANG). The document length is short (2162 chars), but its content is a direct announcement of management change, not an announcement about the publication of another report.
2025-03-18 English
Kallelse till årsstämma i Episurf Medical AB (publ)
AGM Information Classification · 1% confidence The document is titled "Kallelse till årsstämma i Episurf Medical AB (publ)" which translates to "Notice of Annual General Meeting in Episurf Medical AB (publ)". It details the date, time, location, procedures for participation (physical attendance, proxy, or postal voting), and presents a detailed agenda ('FÖRSLAG TILL DAGORDNING') covering items typical for an AGM, such as election of the chairman, approval of financial statements, remuneration reports, guidelines for executive compensation, and election of the board and auditor. This content directly corresponds to the purpose of a notice for an Annual General Meeting. Therefore, the classification is AGM-R.
2025-03-11 Swedish
Notice of Annual General Meeting of Episurf Medical AB (publ)
AGM Information Classification · 1% confidence The document is explicitly titled "Notice of Annual General Meeting of Episurf Medical AB (publ)". It details the date, time, location, procedures for exercising voting rights (in person, proxy, or postal vote), the proposed agenda items (including election of Chairman, Board members, auditor fees, and remuneration reports), and specific proposals from the Nomination Committee regarding board composition and governance. This content perfectly aligns with the definition of materials shared for an Annual General Meeting (AGM). Therefore, the classification is AGM-R.
2025-03-11 English
Annual Report (ESEF) 2024
Annual Report (ESEF) Classification · 1% confidence FY 2024
2025-03-06 Swedish
Episurf Medical AB announces outcome of exercise of warrants of series TO13 B
Share Issue/Capital Change Classification · 1% confidence The document is titled "Episurf Medical AB announces outcome of exercise of warrants of series TO13 B". It details the results of a recent financing/capital structure event (warrant exercise), specifying the number of shares issued, the capital raised (SEK 380,844), and the resulting dilution. This content directly relates to changes in the company's capital structure and fundraising activities. This aligns best with the 'Capital/Financing Update' category (CAP). It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it concerns a specific corporate finance action.
2025-02-25 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.